Jane Gross
Direttore/Membro del Consiglio presso ATYR PHARMA, INC.
Patrimonio netto: 10 380 $ in data 31/05/2024
Profilo
Dr. Jane A.
Gross is an Independent Director at BriaCell Therapeutics Corp., an Independent Director at aTyr Pharma, Inc. and an Independent Director at BriaPro Therapeutics Corp.
She is on the Board of Directors at BriaCell Therapeutics Corp., aTyr Pharma, Inc., Washington Biotechnology & Biomedical Association and BriaPro Therapeutics Corp.
Dr. Gross was previously employed as a Chief Scientific Officer & Senior Vice President by Aptevo Therapeutics, Inc., a VP-Applied Research & Non-Clinical Development by Emergent BioSolutions, Inc., and a Vice President-Immunology Research by ZymoGenetics, Inc. She received her doctorate degree from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ATYR PHARMA, INC.
0.01% | 22/05/2024 | 6 000 ( 0.01% ) | 10 380 $ | 31/05/2024 |
| 20/12/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Jane Gross
| Società | Posizione | Inizio |
|---|---|---|
| ATYR PHARMA, INC. | Direttore/Membro del Consiglio | 28/06/2019 |
| BRIACELL THERAPEUTICS CORP. | Direttore/Membro del Consiglio | 01/11/2021 |
| Washington Biotechnology & Biomedical Association | Direttore/Membro del Consiglio | - |
BriaPro Therapeutics Corp.
 BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jane Gross
| Società | Posizione | Fine |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 14/09/2021 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/08/2016 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/06/2010 |
Formazione di Jane Gross
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Aziende private | 3 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Jane Gross
